Apport des anticorps antinucléaires au cours des maladies neurologiques

dc.contributor.advisorN. KISSANI
dc.contributor.authorFatima-Ezzahra BOUHAIMI
dc.date.accessioned2023-09-19T14:15:05Z
dc.date.accessioned2026-01-28T12:18:30Z
dc.date.available2023-09-19T14:15:05Z
dc.date.issued2021
dc.description.collaboratorN. KISSANI
dc.description.collaboratorF. MANOUDI
dc.description.collaboratorN. LOUHAB
dc.identifier.urihttps://toubkal.imist.ma/handle/123456789/21943
dc.identifier.urihttps://doi.org/10.83129/toubkal-1692
dc.language.isofr
dc.publisherFaculté de Médecine et de Pharmacie, Marrakechfr_FR
dc.publisherSciences médicalesfr_FR
dc.subject.otherNeurologie
dc.subject.specificNeuropathies
dc.subject.specificSclérose en plaque
dc.subject.specificNeuromyélite optique du devic Polyradiculonévrite
dc.subject.specificAnticorps antinucléaires
dc.titleApport des anticorps antinucléaires au cours des maladies neurologiquesfr_FR

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
these193-21.pdf
Size:
1.66 MB
Format:
Adobe Portable Document Format